Viewing Study NCT01573702


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-05-30 @ 12:42 PM
Study NCT ID: NCT01573702
Status: COMPLETED
Last Update Posted: 2021-01-12
First Post: 2012-04-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LCCC 1123
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View